Close

Covidien Completes Transition to New and Improved Magellan Safety Needle

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

The Three Top Benefits of Opting for an Innovative Healthcare Practice

An innovative healthcare practice offers improved patient care through...

Remote Patient Monitoring: A Cost-Effective Solution for Patients and Health Facilities

Remote patient monitoring services are reshaping the healthcare landscape,...

PatientPoint improves health outcomes with new MyHealthTeam partnership

PatientPoint, one of the country’s leading digital health companies...
Covidien, a leading global provider of healthcare products, confirmed the immediate availability of its new and improved Magellan(TM) Safety Hypodermic Needle. The modified design, which is now shipping to all customers, is in stock and available at all Covidien distribution centers in the United States. Beginning today, the previous needle model is no longer being produced or sold.

Covidien, a leading global provider of healthcare products, confirmed the immediate availability of its new and improved Magellan(TM) Safety Hypodermic Needle. The modified design, which is now shipping to all customers, is in stock and available at all Covidien distribution centers in the United States. Beginning today, the previous needle model is no longer being produced or sold.

Jeff Hunt, President, Patient Care and Safety Products, Covidien said, The feedback on the updated Magellan Safety Hypodermic Needle has been extremely positive. We have increased capacity to allow for a smooth transition with our existing customers, and this expansion has enabled us to meet the growing demands of the safety needle market.

The conversion to the improved Magellan Safety Hypodermic Needle has been ongoing since October, and Covidien has worked closely with its existing customers and distribution partners to ensure a smooth transition and uninterrupted supply.

Latest stories

Related stories

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

The Three Top Benefits of Opting for an Innovative Healthcare Practice

An innovative healthcare practice offers improved patient care through...

Remote Patient Monitoring: A Cost-Effective Solution for Patients and Health Facilities

Remote patient monitoring services are reshaping the healthcare landscape,...

PatientPoint improves health outcomes with new MyHealthTeam partnership

PatientPoint, one of the country’s leading digital health companies...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back